Use access key #2 to skip to page content.
$4.01 0.39 (10.77%)
10/10/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

4

Avatar dbhealylongonly (< 20) Submitted: 5/24/08 2:47 PM : Outperform Start Price: $6.11 EXEL Score: 1.41

I usually try to avoid biotech companies, given their inherent volatility (and my propensity to lose sleep when they're in my portfolio!). In this case however, I'm making a speculative bet that these guys will find a way to develop and market their cancer treatment products successfully.

5 Stars - [1881 outperforms / 66 underperforms]

Report this Post Replies: 0 | Reply

Featured Broker Partners